Compare this test’s laboratory options
Broad Coverage Babesia Ab Assay
IGeneX1 test optionFrom $409.50
Broad Coverage Babesia Ab Assay
IGeneXCatalog information reviewed: August 24, 2026 by the Sunridge Medical clinical team.
What this laboratory test evaluates
The Babesia Broad Coverage Antibody Assay (BCA) is a qualitative test designed to detect IgM and IgG antibodies to Babesia antigens in human serum. A positive test suggests exposure to Babesia and should be used in conjunction with the patient's clinical symptoms and history. The BCA Assay is a simple and cost-effective test, which gives either a positive or negative result.
Collection and processing
- Sample type: Serum
- Fasting: No
- Estimated laboratory processing: Results should arrive 10 business days after the lab receives samples.
How Sunridge uses laboratory information
Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.
Before requesting this test
Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.
Related Sunridge care
Learn how Sunridge approaches Lyme Disease and ask whether this test is appropriate for your clinical question.
Common questions about this laboratory test
- What sample does this test require?
- The listed sample type is Serum. Confirm current collection instructions in the approved order.
- Does this test require fasting?
- The current catalog record lists fasting as: No. Follow the instructions supplied with the approved order.
- How long does laboratory processing usually take?
- Results should arrive 10 business days after the lab receives samples.. Timing can change after collection or if a laboratory requires additional review.
About this test
The Babesia Broad Coverage Antibody Assay (BCA) is a qualitative test designed to detect IgM and IgG antibodies to Babesia antigens in human serum. A positive test suggests exposure to Babesia and should be used in conjunction with the patient's clinical symptoms and history. The BCA Assay is a simple and cost-effective test, which gives either a positive or negative result.
Highlighted health areas
- Lyme & tick-borne disease
Biomarkers and report focus
The exact analytes and report format can change. Confirm the current contents in the Fullscript order before payment.
- Babesia spp. IgG
- Babesia spp. IgM